498 Predictors of Platelet Dysfunction in Patients With Traumatic Brain Injury

View at publisher Summarise with VIRAT
Authors: Mehek Dedhia, Daniel D. Cummins, Jueria Rahman, Gregory Kapinos, Laura Salgado-López, Zachary L. Hickman
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Qualitative platelet dysfunction in patients with traumatic brain injury (TBI) is a significant concern as it may potentiate hemorrhage expansion, difficult surgical hemostasis, and worse outcomes. However, data on the incidence and predictors of platelet dysfunction following TBI is sparse. This study utilized thromboelastography with platelet mapping (TEG-PM) to further investigate these factors in TBI patients. METHODS: A retrospective chart review was conducted of adult TBI patients admitted to NYC Health+Hospitals/Elmhurst between 7/1/21-6/30/23 and having at least one TEG-PM data point within 48 hours of admission. Platelet dysfunction was arbitrarily defined as ≥20% inhibition of either the arachidonic acid (AA) or adenosine diphosphate (ADP) pathways. Multivariate models were used to identify predictors of platelet dysfunction. RESULTS: There were 212 patients in the cohort with a mean age of 56.5 years (SD = 20.1) and 25% female. 76.9% of TBI patients had platelet dysfunction and 11.3% had thrombocytopenia (platelet level< 150,000/mm3). The multivariate model revealed that increased age (OR = 1.02 [95% CI 1.00-1.04], p = 0.04) and pre-injury antiplatelet use (OR = 4.69 (95% CI 1.21-31.51], p = 0.049) were associated with an increased risk of AA-pathway dysfunction. There was a trend for thrombocytopenia to additionally independently increase the risk of AA-pathway dysfunction. The model also demonstrated that male sex (OR = 2.75 [95% CI 1.14-6.82], p = 0.03), increased injury Severity Score (OR = 1.06 [95% CI 1.01-1.12], p = 0.026), and blood alcohol level >80 mg/dL (OR = 4.61 [95% CI 1.35-22.00], p = 0.03) were all associated with an increased risk of ADP-pathway dysfunction. Interestingly, prior anticoagulant use was associated with less ADP-pathway dysfunction (OR = 0.25 [95% CI 0.07-0.90], p = 0.03). CONCLUSIONS: This study reveals a high incidence of qualitative platelet dysfunction after TBI, associated with increased patient age, male sex, increased injury severity, elevated blood alcohol level, and pre-injury antiplatelet use. These data may help guide clinical decision-making when treating patients with TBI.

Fields of Study & Subjects

Trauma Hemostasis Coagulopathy Resuscitation Platelet Disorders and Treatments Traumatic Brain Injury and Neurovascular Disturbances

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
147–147
Publication date
26 March 2026
Language
EN